naringenin and Benign Neoplasms, Brain

naringenin has been researched along with Benign Neoplasms, Brain in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Chen, F; Dai, Z; Ma, Y; Song, T; Wang, Y; Wu, J; Zhang, M1
Almaimani, RA; Almasmoum, HA; Alrobaian, M; Baothman, AA; Beg, S; Choudhry, H; Ghaith, MM; Ibrahim, IAA; Panda, SK; Shen, L; Singh, T; Wang, L; Wang, X1
Amirkhosravi, A; Juybari, KB; Mehrabani, M; Mehrbani, M; Mirzamohammdi, S; Nematollahi, MH; Sargazi, ML; Tarzi, ME1
Gabrani, R; Gautam, M1
Chang, YM; Chen, CJ; Chen, KM; Chen, PN; Chen, YY; Hseu, YC; Hsu, LS; Wang, KY; Yeh, KT1
Mahalakshmi, P; Sabarinathan, D; Vanisree, AJ1
Sabarinathan, D; Vanisree, AJ1

Other Studies

7 other study(ies) available for naringenin and Benign Neoplasms, Brain

ArticleYear
Glioma progression is suppressed by Naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivo.
    Investigational new drugs, 2020, Volume: 38, Issue:6

    Topics: Animals; Apoptosis; Astrocytes; Brain Neoplasms; Caspases; Cell Proliferation; Cells, Cultured; Drug Therapy, Combination; Flavanones; Glioma; Humans; Ki-67 Antigen; Male; Mice, Nude; Rats, Sprague-Dawley; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53

2020
Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 138

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Estrogen Antagonists; Female; Flavanones; Glioblastoma; Lipids; Male; Nanoparticles; Paclitaxel; Particle Size; Peptides, Cyclic; Rats; Rats, Wistar

2021
Naringenin attenuates cell viability and migration of C6 glioblastoma cell line: a possible role of hedgehog signaling pathway.
    Molecular biology reports, 2021, Volume: 48, Issue:9

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Flavanones; Glioblastoma; Mice; Rats; Repressor Proteins; Signal Transduction; Smoothened Receptor; Zinc Finger Protein GLI1

2021
Combinatorial Effect of Temozolomide and Naringenin in Human Glioblastoma Multiforme Cell Lines.
    Nutrition and cancer, 2022, Volume: 74, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Flavanones; Glioblastoma; Humans; Temozolomide

2022
Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
    Environmental toxicology, 2019, Volume: 34, Issue:3

    Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Flavanones; Glioblastoma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness

2019
Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats.
    Chemico-biological interactions, 2011, Jan-15, Volume: 189, Issue:1-2

    Topics: Animals; Antioxidants; Ascorbic Acid; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Flavanones; Glioma; Glutathione; Glutathione Peroxidase; Immunohistochemistry; Male; NF-kappa B; Proliferating Cell Nuclear Antigen; Protein Kinase C; Rats; Receptors, Peptide; Thiobarbituric Acid Reactive Substances; Vascular Endothelial Growth Factor A; Vitamin E

2011
Plausible role of naringenin against cerebrally implanted C6 glioma cells in rats.
    Molecular and cellular biochemistry, 2013, Volume: 375, Issue:1-2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cyclooxygenase 2; Flavanones; Gene Expression; Glioma; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Xenograft Model Antitumor Assays

2013